A-109

Quality - General Responsibility and Authority

Section A — General and Personnel Revision 4 4 pages

Original Document

Scanned document (image-only PDF)

Extracted Text

Searchable text extracted from PDF

1.0 Purpose 
 
 The purpose of this procedure is to define and clarify the lines of responsibility and of authority
 for quality matters within Ion Labs, Inc. 
 
 2.0 Scope 
 
 This procedure describes the responsibilities for quality that apply to all personnel at Ion
 Labs, Inc. 
 
 3.0 Responsibility 
 
 3.1. ‘It is the responsibility of Quality Management to take an active role in assuring total
 quality, and reports all areas in which compliance is not satisfactory to senior
 management. 
 
 3.2 ‘It is the responsibility of all personnel to comply with cGMP Quality and Regulatory
 requirements. 
 
 3.3. ‘It is the responsibility of the Quality Unit to ensure that the Quality System complies
 
 with governmental regulatory requirements. The Quality Unit is a separate and distinct
 part of the company and is charged with ensuring the quality and efficacy of the
 company’s products. The Quality Unit reports directly to the CEO. 
 
 3.4 It is the responsibility of the VP of Quality and Regulatory Affairs or designee to serve
 as the primary host for inspections from regulatory agencies and customer audits.
 
 4.0 Definitions 
 
 4.1 cGMP — Current Good Manufacturing Practices 
 
 4.2 SOP - Standard Operating Procedure 
 
 5.0 References 
 
 5.1 21 CFR part 111, 114, 117, 210, 211 - as applicable to Dietary Supplements, Cosmetics
 
 and OTC (reference FDA CFR -Code of Federal Regulations Title 21 for specific part
 
 
 

[SOP 

 Standard Operating Procedure SOP No Rev 
 Quality — General Responsibility and Authority A-109 4 Page 2 of 3 
 
 reference) 
 
 6.0 Procedure 
 
 6.1 Duties of the Quality Unit 
 
 6.1.1 The Quality Unit will have the final responsibility of ensuring the quality of all
 products manufactured, packaged and distributed_by the company. Including the
 
 authority to reject any component or product if any specification is not met.
 
 6.1.2 The Quality Unit will lead any investigations related to customer complaints
 regarding the quality of any products manufactured, packaged, and distributed
 by the company. The Quality Unit will perform a full investigation and
 document any findings which have a negative effect on the quality of the
 
 product. 
 
 6.1.3 The Quality Unit will ensure that all internal and external laboratories and
 testing facilities are qualified to carry out the tests and assays required to ensure
 that raw materials, packaging materials, in-process product, and finished product
 meet the specifications established for them, as well as other appropriate quality
 
 standards. 
 
 6.1.4 Quality Unit personnel are responsible for the actions and procedures in the
 following areas: 
 
 6.1.4.1 Analytical and microbiological testing of raw materials, in-process
 product, and finished product. 
 
 6.1.4.2 Vendor qualification for raw materials and packaging materials.
 
 6.1.4.3. Sampling of raw materials and packaging materials. 
 
 6.1.4.4 Inspection of labels, primary containers, components, and closures for
 acceptance or rejection. 
 
 6.1.4.5 In-process inspection of finished product to ensure that packaging
 specifications are being met. 
 
 6.1.4.6 Conducting line audits during changeovers. 
 
 6.1.4.7 Designing, maintaining, improving, and auditing the quality systems
 
 which ensure the safety, integrity, quality, and purity of all products
 manufactured by the company. 
 
 

[SOP 

 Standard Operating Procedure SOP No | Rev 
 Quality — General Responsibility and Authority A-109 4 | Page 3 of3 
 
 6.1.4.8 Approving SOPs that impact product integrity and cGMP.
 
 6.1.4.9 Final release of finished product 
 
 6.1.4.10 Reviewing and approving reprocessing plans. 
 
 6.1.4.11 Approving capable and reliable contract manufacturers and packagers,
 suppliers of raw and packaging materials, and services that meet or
 exceed the standards set forth by the company. Such providers shall be
 
 subject to qualification and periodic re-evaluation to provide
 confidence in the provider’s ability to meet acceptable standards.
 
 6.1.4.12 Working with production to ensure compliance with cGMP in
 production areas and at contract manufacturing facilities.
 
 6.1.4.13 Conducting internal audits and reviewing results to ensure that the
 
 company and all related systems and procedures meet cGMP
 requirements. 
 
 6.1.4.14 Verifying the compliance of materials with their product specifications
 prior to release of finished product. 
 
 6.1.4.15 Approving manufacturing equipment, facilities, and procedures for use
 
 in production that will lead to manufactured products successfully
 meeting established quality standards. 
 
 6.1.4.16 Staying current with local laws and regulations as well as domestic and
 International agency requirements, including Certifying Bodies (e.g.
 NSF), that may impact product manufactured at the company.
 
 6.1.4.17 Testing to ensure that all product specifications are being met.
 
 6.1.4.18 Assessing manufacturing conditions, new/revised formulations or
 packaging requirements, and new/revised procedures or processes
 before implementation to ensure acceptable quality standards and
 regulatory compliance, as well as requirements specified by the
 
 customer. 
 
 

[SOP 

 Standard Operating Procedure SOP No | Rev Parcdora 
 Quali°t y — General Responsibon ileyie ty and Authori°t y ee e ‘ ag:e +0 
 
 7.0 Revision History 

| Rev | Date | Description of Changes | CCR # | By |
|-----|----------|------------------------|-------|----|
| 0 | 06/04/10 | New - - Changed SOP format, SOP title, and SOP number. Updated SOP to panei be consistent with restructured quality system. aid ee Hoare | - | - |
| 2 | 06/24/15 | Biennial review: updated SOP format. | 15-0569 | S. Millar |
| 3 | 01/03/19 | Scheduled review: update responsibilities. | 19-0016 | K. Burris |
| 4 | 08/04/21 | Added 21 CFR parts. Added statement of authority to reject in CC- section 6.1.1. Added further clarification to section 6.1.4.16 | 21-0309 | C. Mitchell |